Biological descriptionD1-like dopamine receptor agonist. pKi values are 9 (D1), 6.8 (D2), 5.3 (D3), 6.0 (D4) and 9.3 (D5). Ki values are 151 and 2364 nM for D1-like and D2-like dopamine receptors, respectively. Centrally active upon systemic administration.
Chemical name(±)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride
Storage instructionsStore at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
Solubility overviewSoluble in water to 50 mM (with warming) and in DMSO to 100 mM
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
References for (±)-SKF38393 hydrochloride (ab120740)
This product has been referenced in:
Manrique-Maldonado G et al. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type. Basic Clin Pharmacol Toxicol109:506-12 (2011).
Read more (PubMed: 21740529) »
Clark AH et al. Assessment of dopamine D1 receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393. Bioorg Med Chem19:5420-31 (2011).
Read more (PubMed: 21862338) »
Flournoy WS et al. Pharmacologic identification of putative D1 dopamine receptors in feline kidneys. J Vet Pharmacol Ther26:283-90 (2003).
Read more (PubMed: 12887611) »
Huang KX & Walters JR Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. J Pharmacol Exp Ther271:1434-43 (1994).
Read more (PubMed: 7996456) »